Report cover image

Genome Editing Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

Publisher Prof-Research
Published Mar 23, 2025
Length 105 Pages
SKU # PROF19876424

Description

Genome Editing Market Summary

Genome Editing encompasses technologies that precisely alter DNA sequences, revolutionizing medicine, agriculture, and biotechnology with tools like CRISPR, TALENs, and zinc-finger nucleases. This market thrives on its ability to address genetic diseases, enhance crop traits, and accelerate drug discovery, blending cutting-edge science with practical applications. Positioned within the biotech and life sciences sector, it relies on sophisticated molecular tools, regulatory frameworks, and ethical considerations. The market surges on breakthroughs in gene therapy, growing investment in precision medicine, and demand for sustainable agriculture, with next-generation editing tools enhancing specificity and scalability. It serves researchers, clinicians, and agribusinesses seeking transformative solutions across diverse domains.

Market Size and Growth Forecast
The global Genome Editing market is valued between USD 8 billion and USD 10 billion in 2025, with a projected CAGR of 12.0% to 14.0% from 2025 to 2030, reaching USD 16 billion to USD 20 billion by 2030. Growth reflects technological advancements and expanding applications.

Regional Analysis
North America: Growing at 10-12%, the U.S. leads with robust biotech R&D, trending toward therapeutic applications.
Europe: With a 10-11% growth rate, Germany, UK, and France dominate, driven by research and regulation, with agbiotech trending.
Asia Pacific: Exhibiting a 14-16% growth rate, China, Japan, and South Korea excel, fueled by investment and healthcare innovation.
Middle East and Africa (MEA): Growing at 8-10%, UAE advances with biotech adoption, focusing on research hubs.
South America: With a 9-11% growth rate, Brazil leads with agricultural applications, emphasizing crop enhancement.

Product Type Analysis
First-generation nuclease-based genome editing: Expected at 10-12%, these include ZFNs and TALENs, with steady use in research, trending toward cost reduction.
Next-generation genome editing: Projected at 13-15%, CRISPR dominates with precision and scalability, trending toward therapeutic breakthroughs.

Key Market Players
Beam Therapeutics Inc.: A pioneer in base editing for precision medicine.
Verve Therapeutics Inc.: A trailblazer targeting cardiovascular gene therapies.
Sangamo Therapeutics Inc.: A veteran in zinc-finger nuclease innovation.
Precision BioSciences Inc.: A dynamic force in ARCUS editing technology.
Cellectis S.A.: A creative leader in allogeneic gene therapies.
bluebird bio Inc.: A robust player in genetic disease treatments.
Arbor Biotech: An emerging innovator in plant genome editing.
Chroma Medicine Inc.: A spirited firm in epigenetic editing solutions.
Mammoth Biosciences: A cutting-edge provider of CRISPR diagnostics.
Scribe Therapeutics: An agile pioneer in CRISPR engineering.
Tessera Therapeutics: A visionary in gene writing technologies.
Tome Biosciences: A bold innovator in genomic solutions.
Tune Therapeutics Inc.: A creative force in epigenetic tuning.
Metagenomi Technologies LLC: A rising star in metagenomic editing tools.

Porter’s Five Forces Analysis
Threat of New Entrants: Medium, with high tech barriers, but startups emerge with novel tools.
Threat of Substitutes: Low, as few alternatives match editing precision, though traditional methods linger.
Bargaining Power of Buyers: Medium, with research institutes negotiating, end-users less so.
Bargaining Power of Suppliers: Medium, with reliance on biotech inputs balanced by scale.
Competitive Rivalry: High, with fierce innovation and IP battles.

Market Opportunities and Challenges
Opportunities
Gene therapy breakthroughs: Rising genetic disease treatments drive demand, targeting unmet medical needs.
Agricultural innovation: Enhanced crops boost food security, expanding agbiotech applications.
Precision medicine growth: Personalized healthcare elevates editing, supporting therapeutic scalability.
Tech advancements: Next-gen tools improve specificity, broadening market reach.
Investment surge: Growing biotech funding fuels R&D, accelerating innovation.
Challenges
Ethical concerns: Regulatory and societal debates slow adoption, needing balanced oversight.
High costs: R&D and deployment expenses limit accessibility, challenging scale.
IP disputes: Patent battles hinder progress, raising legal costs.
Technical complexity: Precision editing requires expertise, posing barriers in some regions.
Regulatory delays: Strict approvals slow market entry, impacting growth.

Table of Contents

105 Pages
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Genome Editing Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Genome Editing Market in North America (2020-2030)
8.1 Genome Editing Market Size
8.2 Genome Editing Market by End Use
8.3 Competition by Players/Suppliers
8.4 Genome Editing Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Genome Editing Market in South America (2020-2030)
9.1 Genome Editing Market Size
9.2 Genome Editing Market by End Use
9.3 Competition by Players/Suppliers
9.4 Genome Editing Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Genome Editing Market in Asia & Pacific (2020-2030)
10.1 Genome Editing Market Size
10.2 Genome Editing Market by End Use
10.3 Competition by Players/Suppliers
10.4 Genome Editing Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Genome Editing Market in Europe (2020-2030)
11.1 Genome Editing Market Size
11.2 Genome Editing Market by End Use
11.3 Competition by Players/Suppliers
11.4 Genome Editing Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Genome Editing Market in MEA (2020-2030)
12.1 Genome Editing Market Size
12.2 Genome Editing Market by End Use
12.3 Competition by Players/Suppliers
12.4 Genome Editing Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Genome Editing Market (2020-2025)
13.1 Genome Editing Market Size
13.2 Genome Editing Market by End Use
13.3 Competition by Players/Suppliers
13.4 Genome Editing Market Size by Type
Chapter 14 Global Genome Editing Market Forecast (2025-2030)
14.1 Genome Editing Market Size Forecast
14.2 Genome Editing Application Forecast
14.3 Competition by Players/Suppliers
14.4 Genome Editing Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Beam Therapeutics Inc.
15.1.1 Company Profile
15.1.2 Main Business and Genome Editing Information
15.1.3 SWOT Analysis of Beam Therapeutics Inc.
15.1.4 Beam Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.2 Verve Therapeutics Inc.
15.2.1 Company Profile
15.2.2 Main Business and Genome Editing Information
15.2.3 SWOT Analysis of Verve Therapeutics Inc.
15.2.4 Verve Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sangamo Therapeutics Inc.
15.3.1 Company Profile
15.3.2 Main Business and Genome Editing Information
15.3.3 SWOT Analysis of Sangamo Therapeutics Inc.
15.3.4 Sangamo Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.4 Precision BioSciences Inc.
15.4.1 Company Profile
15.4.2 Main Business and Genome Editing Information
15.4.3 SWOT Analysis of Precision BioSciences Inc.
15.4.4 Precision BioSciences Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.5 Cellectis S.A.
15.5.1 Company Profile
15.5.2 Main Business and Genome Editing Information
15.5.3 SWOT Analysis of Cellectis S.A.
15.5.4 Cellectis S.A. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.6 bluebird bio Inc.
15.6.1 Company Profile
15.6.2 Main Business and Genome Editing Information
15.6.3 SWOT Analysis of bluebird bio Inc.
15.6.4 bluebird bio Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.7 Arbor Biotech
15.7.1 Company Profile
15.7.2 Main Business and Genome Editing Information
15.7.3 SWOT Analysis of Arbor Biotech
15.7.4 Arbor Biotech Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.8 Chroma Medicine Inc.
15.8.1 Company Profile
15.8.2 Main Business and Genome Editing Information
15.8.3 SWOT Analysis of Chroma Medicine Inc.
15.8.4 Chroma Medicine Inc. Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.9 Mammoth Biosciences
15.9.1 Company Profile
15.9.2 Main Business and Genome Editing Information
15.9.3 SWOT Analysis of Mammoth Biosciences
15.9.4 Mammoth Biosciences Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
15.10 Scribe Therapeutics
15.10.1 Company Profile
15.10.2 Main Business and Genome Editing Information
15.10.3 SWOT Analysis of Scribe Therapeutics
15.10.4 Scribe Therapeutics Genome Editing Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Genome Editing Report
Table Data Sources of Genome Editing Report
Table Major Assumptions of Genome Editing Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Genome Editing Picture
Table Genome Editing Classification
Table Genome Editing Applications
Table Drivers of Genome Editing Market
Table Restraints of Genome Editing Market
Table Opportunities of Genome Editing Market
Table Threats of Genome Editing Market
Table Covid-19 Impact For Genome Editing Market
Table Raw Materials Suppliers
Table Different Production Methods of Genome Editing
Table Cost Structure Analysis of Genome Editing
Table Key End Users
Table Latest News of Genome Editing Market
Table Merger and Acquisition
Table Planned/Future Project of Genome Editing Market
Table Policy of Genome Editing Market
Table 2020-2030 North America Genome Editing Market Size
Figure 2020-2030 North America Genome Editing Market Size and CAGR
Table 2020-2030 North America Genome Editing Market Size by Application
Table 2020-2025 North America Genome Editing Key Players Revenue
Table 2020-2025 North America Genome Editing Key Players Market Share
Table 2020-2030 North America Genome Editing Market Size by Type
Table 2020-2030 United States Genome Editing Market Size
Table 2020-2030 Canada Genome Editing Market Size
Table 2020-2030 Mexico Genome Editing Market Size
Table 2020-2030 South America Genome Editing Market Size
Figure 2020-2030 South America Genome Editing Market Size and CAGR
Table 2020-2030 South America Genome Editing Market Size by Application
Table 2020-2025 South America Genome Editing Key Players Revenue
Table 2020-2025 South America Genome Editing Key Players Market Share
Table 2020-2030 South America Genome Editing Market Size by Type
Table 2020-2030 Brazil Genome Editing Market Size
Table 2020-2030 Argentina Genome Editing Market Size
Table 2020-2030 Chile Genome Editing Market Size
Table 2020-2030 Peru Genome Editing Market Size
Table 2020-2030 Asia & Pacific Genome Editing Market Size
Figure 2020-2030 Asia & Pacific Genome Editing Market Size and CAGR
Table 2020-2030 Asia & Pacific Genome Editing Market Size by Application
Table 2020-2025 Asia & Pacific Genome Editing Key Players Revenue
Table 2020-2025 Asia & Pacific Genome Editing Key Players Market Share
Table 2020-2030 Asia & Pacific Genome Editing Market Size by Type
Table 2020-2030 China Genome Editing Market Size
Table 2020-2030 India Genome Editing Market Size
Table 2020-2030 Japan Genome Editing Market Size
Table 2020-2030 South Korea Genome Editing Market Size
Table 2020-2030 Southeast Asia Genome Editing Market Size
Table 2020-2030 Australia Genome Editing Market Size
Table 2020-2030 Europe Genome Editing Market Size
Figure 2020-2030 Europe Genome Editing Market Size and CAGR
Table 2020-2030 Europe Genome Editing Market Size by Application
Table 2020-2025 Europe Genome Editing Key Players Revenue
Table 2020-2025 Europe Genome Editing Key Players Market Share
Table 2020-2030 Europe Genome Editing Market Size by Type
Table 2020-2030 Germany Genome Editing Market Size
Table 2020-2030 France Genome Editing Market Size
Table 2020-2030 United Kingdom Genome Editing Market Size
Table 2020-2030 Italy Genome Editing Market Size
Table 2020-2030 Spain Genome Editing Market Size
Table 2020-2030 Belgium Genome Editing Market Size
Table 2020-2030 Netherlands Genome Editing Market Size
Table 2020-2030 Austria Genome Editing Market Size
Table 2020-2030 Poland Genome Editing Market Size
Table 2020-2030 Russia Genome Editing Market Size
Table 2020-2030 MEA Genome Editing Market Size
Figure 2020-2030 MEA Genome Editing Market Size and CAGR
Table 2020-2030 MEA Genome Editing Market Size by Application
Table 2020-2025 MEA Genome Editing Key Players Revenue
Table 2020-2025 MEA Genome Editing Key Players Market Share
Table 2020-2030 MEA Genome Editing Market Size by Type
Table 2020-2030 Egypt Genome Editing Market Size
Table 2020-2030 Israel Genome Editing Market Size
Table 2020-2030 South Africa Genome Editing Market Size
Table 2020-2030 Gulf Cooperation Council Countries Genome Editing Market Size
Table 2020-2030 Turkey Genome Editing Market Size
Table 2020-2025 Global Genome Editing Market Size by Region
Table 2020-2025 Global Genome Editing Market Size Share by Region
Table 2020-2025 Global Genome Editing Market Size by Application
Table 2020-2025 Global Genome Editing Market Share by Application
Table 2020-2025 Global Genome Editing Key Vendors Revenue
Figure 2020-2025 Global Genome Editing Market Size and Growth Rate
Table 2020-2025 Global Genome Editing Key Vendors Market Share
Table 2020-2025 Global Genome Editing Market Size by Type
Table 2020-2025 Global Genome Editing Market Share by Type
Table 2025-2030 Global Genome Editing Market Size by Region
Table 2025-2030 Global Genome Editing Market Size Share by Region
Table 2025-2030 Global Genome Editing Market Size by Application
Table 2025-2030 Global Genome Editing Market Share by Application
Table 2025-2030 Global Genome Editing Key Vendors Revenue
Figure 2025-2030 Global Genome Editing Market Size and Growth Rate
Table 2025-2030 Global Genome Editing Key Vendors Market Share
Table 2025-2030 Global Genome Editing Market Size by Type
Table 2025-2030 Genome Editing Global Market Share by Type

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us